About: Maribavir

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV). The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue. Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication. Maribavir was approved for medical use in the United States in November 2021, and in the European Union in November 2022.

Property	Value
dbo:abstract	Maribavir (Markenname Livtencity) ist ein antiviraler Wirkstoff, der zur Behandlung des Zytomegalievirus (CMV) nach einer Transplantation eingesetzt wird. Maribavir wurde im November 2021 in den Vereinigten Staaten für die medizinische Verwendung zugelassen. (de) Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV). The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue. Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication. Maribavir was approved for medical use in the United States in November 2021, and in the European Union in November 2022. (en)
dbo:alternativeName	Livtencity (en)
dbo:casNumber	176161-24-3
dbo:chEMBL	515408
dbo:drugbank	DB06234
dbo:fdaUniiCode	PTB4X93HE1
dbo:kegg	D04859
dbo:pubchem	471161
dbo:thumbnail	wiki-commons:Special:FilePath/Maribavir.svg?width=300
dbo:wikiPageExternalLink	https://druginfo.nlm.nih.gov/drugportal/name/maribavir
dbo:wikiPageID	21481689 (xsd:integer)
dbo:wikiPageLength	17837 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1123880289 (xsd:integer)
dbo:wikiPageWikiLink	dbr:FDA_Fast_Track_Development_Program dbr:Priority_review dbr:Cytomegalovirus dbr:Valganciclovir dbr:ViroPharma dbr:Indication_(medicine) dbc:Chloroarenes dbc:Isopropyl_compounds dbr:Oral_administration dbr:Orphan_drug dbr:Cidofovir dbr:Enzyme dbr:Ganciclovir dbr:GlaxoSmithKline dbr:Statistically_significant dbr:Stem_cell dbr:Clinical_trial dbr:Committee_for_Medicinal_Products_for_Human_Use dbr:Hematopoietic_stem_cell dbr:Protein_kinase dbc:Benzimidazoles dbc:Nucleosides dbc:Orphan_drugs dbr:European_Medicines_Agency dbr:Food_and_Drug_Administration dbr:Foscarnet dbr:Breakthrough_therapy dbr:Prophylaxis dbc:Breakthrough_therapy dbc:Anti-herpes_virus_drugs dbr:Organ_transplantation dbr:Tissue_engineering dbr:Bone_marrow_transplant dbr:Antiviral_medication dbr:Intent-to-treat dbr:Hematopoietic_stem_cell_transplant dbr:PUL97 dbr:UL97
dbp:atcPrefix	J05 (en)
dbp:atcSuffix	AX10 (en)
dbp:c	15 (xsd:integer)
dbp:casNumber	176161 (xsd:integer)
dbp:chembl	515408 (xsd:integer)
dbp:chemspiderid	413807 (xsd:integer)
dbp:cl	2 (xsd:integer)
dbp:dailymedid	Maribavir (en)
dbp:drugbank	DB06234 (en)
dbp:h	19 (xsd:integer)
dbp:iupacName	-2 (xsd:integer)
dbp:kegg	D04859 (en)
dbp:legalCa	Rx-only (en)
dbp:legalEu	Rx-only (en)
dbp:legalUs	Rx-only (en)
dbp:n	3 (xsd:integer)
dbp:niaidChemdb	70966 (xsd:integer)
dbp:o	4 (xsd:integer)
dbp:pubchem	471161 (xsd:integer)
dbp:routesOfAdministration	dbr:Oral_administration
dbp:smiles	CCNc1nc2ccCl (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	KJFBVJALEQWJBS-XUXIUFHCSA-N (en)
dbp:synonyms	1263 (xsd:integer)
dbp:tradename	Livtencity (en)
dbp:unii	PTB4X93HE1 (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	450846483 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Cite_web dbt:Convert dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Use_dmy_dates dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite dbt:DNA_antivirals dbt:Drugs.com dbt:ClinicalTrialsGov
dct:subject	dbc:Chloroarenes dbc:Isopropyl_compounds dbc:Benzimidazoles dbc:Nucleosides dbc:Orphan_drugs dbc:Breakthrough_therapy dbc:Anti-herpes_virus_drugs
gold:hypernym	dbr:Candidate
rdf:type	owl:Thing dbo:Person dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAnti-herpesVirusDrugs yago:WikicatAntivirals yago:Agent114778436 yago:Antiviral102725367 yago:CausalAgent100007347 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090 umbel-rc:DrugProduct
rdfs:comment	Maribavir (Markenname Livtencity) ist ein antiviraler Wirkstoff, der zur Behandlung des Zytomegalievirus (CMV) nach einer Transplantation eingesetzt wird. Maribavir wurde im November 2021 in den Vereinigten Staaten für die medizinische Verwendung zugelassen. (de) Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV). The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue. Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication. Maribavir was approved for medical use in the United States in November 2021, and in the European Union in November 2022. (en)
rdfs:label	Maribavir (de) Maribavir (en)
owl:sameAs	freebase:Maribavir yago-res:Maribavir wikidata:Maribavir dbpedia-de:Maribavir dbpedia-fa:Maribavir dbpedia-sh:Maribavir dbpedia-sr:Maribavir https://global.dbpedia.org/id/4rSaC
prov:wasDerivedFrom	wikipedia-en:Maribavir?oldid=1123880289&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Maribavir.svg
foaf:isPrimaryTopicOf	wikipedia-en:Maribavir
is dbo:wikiPageRedirects of	dbr:ATC_code_J05AX10 dbr:ATCvet_code_QJ05AX10 dbr:Livtencity dbr:Cl2H19N3O4
is dbo:wikiPageWikiLink of	dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:ViroPharma dbr:ATC_code_J05AX10 dbr:ATCvet_code_QJ05AX10 dbr:ATC_code_J05 dbr:Livtencity dbr:Cl2H19N3O4
is foaf:primaryTopic of	wikipedia-en:Maribavir